샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793787

세계의 호흡기 내시경 치료 기기 시장

Respiratory Endotherapy Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 381 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

호흡기 내시경 치료 기기 세계 시장은 2030년까지 17억 달러에 달할 전망

2024년에 14억 달러로 추정되는 호흡기 내시경 치료 기기 세계 시장은 분석 기간인 2024-2030년에 CAGR 3.6%로 성장하여 2030년에는 17억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 진단 기기는 CAGR 2.9%를 기록하며 분석 기간 종료까지 10억 달러에 달할 것으로 예측됩니다. 치료 기기 부문의 성장률은 분석 기간 동안 CAGR 4.7%로 추정됩니다.

미국 시장은 추정 3억 8,330만 달러, 중국은 CAGR 6.6%로 성장 예측

미국의 호흡기 내시경 치료 기기 시장은 2024년에 3억 8,330만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 3억 4,650만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.5%와 2.8%로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%로 성장할 것으로 예측됩니다.

세계의 호흡기 내시경 치료 기기 시장 - 주요 동향과 촉진요인 정리

기도 내부 기술의 발전이 폐의 중재적 시술을 어떻게 변화시킬 것인가?

만성 및 급성 호흡기질환 관리에서 내시경 치료의 역할을 높이는 것은 무엇인가?

만성 및 급성 호흡기질환의 진단 및 치료에서 호흡기 내과가 보다 최소침습적이고 정밀한 유도 치료로 전환함에 따라 호흡기 내시경 치료 기기 시장은 빠르게 주목을 받고 있습니다. 만성폐쇄성폐질환(COPD), 기관지 협착, 중추성 기도폐쇄, 폐암 등의 질환에서는 폐쇄된 기도의 확장, 스텐트 삽입, 절제 등 치료적 내시경 검사가 필요한 경우가 많습니다. 이러한 치료는 풍선 확장기, 전기 수술용 프로브, 냉동 치료 시스템, 기도 스텐트 등 첨단 내시경 치료 장비를 이용하여 주변 조직에 대한 외상을 최소화하면서 표적 치료를 가능하게 하는 치료법이 많이 시행되고 있습니다.

도시 공해, 흡연, 고령화, 코로나 이후 합병증으로 악화되는 호흡기질환의 부담이 증가함에 따라 큰 수술에 의존하지 않고 호흡기질환을 완화하는 기술이 절실히 요구되고 있습니다. 이런 점에서 내시경 치료는 외래에서 치료가 가능하고, 회복에 걸리는 시간이 짧고, 합병증 위험이 낮다는 점 등 몇 가지 장점이 있습니다. 예를 들어 폐암의 경우 기관지경을 이용한 치료는 완화적 감압뿐만 아니라 광선역학치료, 근접방사선치료 등의 국소치료에도 사용되고 있습니다. 이러한 변화는 시술의 안전성과 진단 정확도를 향상시키는 영상 유도 내비게이션과 소형화된 기기의 개선으로 뒷받침되고 있으며, 폐 전문의는 더 높은 정확도로 더 깊은 폐 부위에 접근할 수 있게 되었습니다.

내시경 치료 기기의 성능을 변화시키는 장비와 영상 진단의 혁신이란?

기술 혁신은 호흡기 내시경 치료 기기의 성능, 디자인, 애플리케이션을 재구성하고 있습니다. 주요 발전 중 하나는 복잡한 기도 해부학에서 탐색을 개선하고 교차 오염의 위험을 줄이면서 교차 오염의 위험을 줄일 수 있는 조종 가능한 일회용 기관지경 개발입니다. 이러한 일회용 장치는 실시간 투시 시스템 및 전자기 내비게이션 시스템과 결합하여 임상의가 이전에는 접근하기 어려웠던 병변을 치료할 수 있게 해줍니다. 또한, 팽창 프로파일을 조절할 수 있는 풍선 확장 시스템은 단계별 압력 조절이 가능하여 확장 시술 중 기도 외상 위험을 줄입니다.

또 다른 중요한 추세는 전기 수술 및 냉동 절제 기기의 소형화 및 기관지경 플랫폼으로의 통합입니다. 생검이나 절제를 위해 비정상 조직을 정확하게 동결할 수 있는 크라이오 프로브는 말초 폐 시술에 적합한 유연한 형태로 제공되고 있습니다. 마찬가지로 아르곤 플라즈마 응고요법(APC)과 고주파 소작요법(RFA)도 객혈 억제와 종양 제거를 위해 경기관지용으로 적응증이 확대되고 있습니다. 첨단 스텐트 전달 시스템(종종 사전 장착, 자가 확장, 길이 및 직경 맞춤화 가능)은 기도 협착 및 수술 후 협착의 치료 결과를 개선하고 있습니다. 또한, 내시경 치료 기구는 온도, 압력, 위치 결정에 대한 실시간 피드백을 얻을 수 있는 센서를 내장하여 설계되고 있으며, 이를 통해 인위적인 실수를 최소화하고 시술의 재현성을 높이고 있습니다.

임상 프로토콜과 지역 의료 인프라가 시장 침투를 어떻게 형성할 것인가?

호흡기 내시경 치료 기기의 보급은 지역 내 임상 프로토콜, 상환 프레임워크, 중재적 팔모노로지 인프라의 유무에 따라 크게 영향을 받습니다. 미국, 독일, 일본, 한국 등 고소득 지역에서는 호흡기 내시경 치료 기기이 진단과 치료 목적으로 3차 의료기관에서 표준 치료로 채택되고 있습니다. 이들 국가의 병원에는 첨단 영상 진단 장비, 통합 수술실, 모든 장비를 사용할 수 있는 훈련된 중재적 파모니스트 등이 갖추어져 있습니다. 이들 지역에서는 최소침습적 시술과 급성기 이후 호흡기 치료에 대한 급여도 확립되어 있어 도입이 더욱 촉진되고 있습니다.

반면, 동남아시아, 동유럽, 라틴아메리카 등 중산층 지역에서는 호흡기 내 치료에 대한 관심이 높아지고 있지만, 비용과 제한된 기술적 전문 지식으로 인해 도입에 제약이 있는 경우가 많습니다. 그럼에도 불구하고, 민관 파트너십의 확대와 원격의료 기반 교육 플랫폼이 기술 격차 해소에 도움이 되고 있습니다. 인도, 중국, 브라질에서는 호흡기질환의 조기 발견 및 조기 관리를 목표로 하는 정부 및 비영리 단체의 이니셔티브가 비용 효율적이고 현지에 적합한 내시경 치료 솔루션에 대한 수요를 촉진하고 있습니다. 도시 병원에서는 이동식 기관지 내시경 검사실과 외래 중재 프로그램이 등장하기 시작했으며, 더 많은 환자들이 내시경 치료를 받을 수 있게 되었습니다.

호흡기 내시경 치료 기기 시장의 장기적인 성장을 뒷받침하는 요인은 무엇일까?

호흡기 내시경 치료 기기 시장의 성장은 만성 호흡기질환의 유병률 증가, 최소침습적 중재에 대한 수요 증가, 치료 도구의 지속적인 혁신 등 여러 요인에 의해 이루어지고 있습니다. 주요 성장 요인은 외래 환자 치료 모델과 외래 환자 개입으로의 전환입니다. 의료 시스템은 입원 비용과 수술 합병증 감소에 대한 압박을 받고 있으며, 기관지 내시경 치료는 가치 기반 치료의 목표에 부합하는 실행 가능한 대안을 제공합니다. 기관지 내시경 치료의 수요는 저선량 CT 스캔이나 AI 지원 엑스레이 검사로 발견되는 호흡기 및 흉부 질환의 조기 진단이 증가함에 따라 더욱 증가하고 있습니다.

또한, 인터벤션 파스모놀로지가 뚜렷한 하위 전문 분야로서 역할이 확대됨에 따라 첨단 내시경 치료 도구를 채택할 수 있는 탄탄한 임상적 기반이 형성되고 있습니다. 병원과 교육 센터는 새로운 세대의 폐 전문의를 지원하기 위해 시뮬레이션 연구실, 하이브리드 수술실, AI 가이드 수술 계획 시스템에 투자하고 있습니다. 기술적으로는 로봇공학, 영상 진단, 재료과학의 융합이 진행되고 있으며, 자율주행 내비게이션, 고정밀 약물전달, 항염증 특성을 가진 나노코팅 스텐트 등의 가능성을 열어가고 있습니다.

마지막으로, WHO의 'NCDs 예방 및 통제를 위한 세계 행동 계획'과 같이 호흡기 건강에 초점을 맞춘 세계 보건 정책 이니셔티브는 이 분야에 대한 투자와 기술 혁신에 유리한 정책 환경을 조성하고 있습니다. 인구 고령화, 도시 지역에서의 유병률 증가, 호흡기 전염병의 지속적인 위협으로 인해 폐 건강 관리에서 내시경 치료의 역할은 크게 성장할 것으로 예상됩니다. 앞으로의 의료기기는 더욱 저렴하고, 개인화되고, 디지털로 연결될 것이며, 이는 이 영향력 있는 의료 분야의 장기적인 성장 궤도를 보장할 것으로 예상됩니다.

부문

기기(진단 기기, 치료 기기), 전문가(병원 전문가, 진단 센터 전문가, 외래 수술 센터 전문가), 최종사용자(말초혈관 인터벤션 최종사용자, 혈관내 인터벤션 최종사용자, 심장 최종사용자, 인터벤션 영상의학 최종사용자, 정맥 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • Ambu
  • Armstrong Medical
  • Boston Scientific
  • CONMED Corporation
  • Cook Medical
  • Dragerwerk
  • Fisher & Paykel Healthcare
  • Flexicare Medical
  • Getinge
  • Halyard Health(Avanos Medical)
  • Hudson RCI
  • Intersurgical
  • Karl Storz
  • Laerdal Medical
  • Medtronic
  • Olympus
  • PENTAX Medical
  • Philips(Philips Respironics)
  • ResMed
  • Teleflex

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.26

Global Respiratory Endotherapy Devices Market to Reach US$1.7 Billion by 2030

The global market for Respiratory Endotherapy Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Therapeutic Devices segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$383.3 Million While China is Forecast to Grow at 6.6% CAGR

The Respiratory Endotherapy Devices market in the U.S. is estimated at US$383.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$346.5 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Respiratory Endotherapy Devices Market - Key Trends & Drivers Summarized

Inside the Airway: How Technological Advancements Are Transforming Interventional Pulmonary Procedures

What Is Elevating the Role of Endotherapy in Managing Chronic and Acute Respiratory Disorders?

The respiratory endotherapy devices market is rapidly gaining prominence as pulmonology transitions toward less invasive, precision-guided interventions for the diagnosis and treatment of both chronic and acute airway disorders. Conditions such as chronic obstructive pulmonary disease (COPD), bronchial stenosis, central airway obstruction, and lung cancers often require therapeutic endoscopy involving dilation, stenting, or ablation of obstructed airways. These interventions are increasingly being performed using advanced endotherapy devices, including balloon dilators, electrosurgical probes, cryotherapy systems, and airway stents, which enable targeted treatment with minimal trauma to surrounding tissues.

The rising burden of respiratory diseases-exacerbated by urban pollution, smoking, aging populations, and post-COVID complications-has created an urgent need for technologies that provide relief without resorting to major surgery. Endotherapy offers several advantages in this regard, such as outpatient feasibility, shorter recovery time, and lower risk of complications. In the context of lung cancer, for instance, bronchoscopic interventions are being used not only for palliative decompression but also for delivering localized therapy such as photodynamic treatment or brachytherapy. These shifts are supported by improvements in imaging-guided navigation and miniaturized instrumentation that enhance procedural safety and diagnostic accuracy, allowing pulmonologists to access deeper lung segments with higher precision.

What Innovations in Instrumentation and Imaging Are Transforming Endotherapy Device Performance?

Technological innovation is reshaping the performance, design, and application of respiratory endotherapy devices. One of the major advancements is the development of steerable, single-use bronchoscopes that reduce cross-contamination risks while improving navigation in complex airway anatomies. These disposable devices, paired with real-time fluoroscopy or electromagnetic navigation systems, enable clinicians to deliver therapy to previously inaccessible lesions. Moreover, balloon dilation systems with adjustable inflation profiles now provide graduated pressure control, reducing the risk of airway trauma during dilation procedures.

Another significant trend is the miniaturization and integration of electrosurgical and cryoablation devices into bronchoscopic platforms. Cryoprobes, capable of precisely freezing abnormal tissue for biopsy or ablation, are now available in flexible formats suitable for peripheral lung procedures. Similarly, argon plasma coagulation (APC) and radiofrequency ablation (RFA) tools are being adapted for transbronchial use to control hemoptysis or debulk tumors. Advanced stent delivery systems-often preloaded, self-expanding, and customizable in length and diameter-are improving treatment outcomes in airway stenosis and post-surgical strictures. Furthermore, endotherapy devices are now being designed with embedded sensors for real-time feedback on temperature, pressure, and positioning, thereby minimizing human error and enhancing procedural reproducibility.

How Do Clinical Protocols and Regional Healthcare Infrastructure Shape Market Penetration?

The adoption of respiratory endotherapy devices is highly influenced by local clinical protocols, reimbursement frameworks, and the availability of interventional pulmonology infrastructure. In high-income regions such as the U.S., Germany, Japan, and South Korea, respiratory endotherapy is increasingly being adopted as standard-of-care in tertiary centers for both diagnostic and therapeutic purposes. Hospitals in these countries are equipped with advanced imaging modalities, integrated operating suites, and trained interventional pulmonologists who can utilize the full spectrum of devices. Reimbursement for minimally invasive procedures and post-acute respiratory care is also well established in these regions, further encouraging adoption.

In contrast, middle-income regions such as Southeast Asia, Eastern Europe, and Latin America are witnessing growing interest in respiratory endotherapy, but uptake is often constrained by cost considerations and limited technical expertise. Nevertheless, the expansion of public-private partnerships and telemedicine-based training platforms is helping to bridge the skills gap. In India, China, and Brazil, government and non-profit initiatives targeting early detection and management of respiratory diseases are spurring demand for cost-effective, locally adapted endotherapy solutions. Mobile bronchoscopy units and outpatient interventional programs are beginning to appear in urban hospitals, bringing endotherapy within reach of a broader patient demographic.

What Is Sustaining Long-Term Growth in the Respiratory Endotherapy Devices Market?

The growth in the respiratory endotherapy devices market is driven by several factors, including the increasing prevalence of chronic respiratory diseases, rising demand for minimally invasive interventions, and ongoing innovation in procedural tools. A major growth driver is the shift toward ambulatory care models and outpatient interventions. With healthcare systems under pressure to reduce inpatient costs and surgical complications, bronchoscopic endotherapy provides a viable alternative that aligns with the goals of value-based care. The demand for these procedures is further fueled by the rise in early diagnosis of respiratory and thoracic conditions, often detected through low-dose CT scans and AI-assisted radiology.

In addition, the expanding role of interventional pulmonology as a distinct subspecialty is creating a robust clinical base for the adoption of advanced endotherapy tools. Hospitals and training centers are investing in simulation labs, hybrid ORs, and AI-guided procedural planning systems to support a new generation of pulmonary specialists. From a technology standpoint, the ongoing convergence of robotics, imaging, and material science is unlocking possibilities such as autonomous navigation, precision drug delivery, and nanocoated stents with anti-inflammatory properties.

Finally, global health policy initiatives focusing on respiratory health-such as the WHO’s Global Action Plan for the Prevention and Control of NCDs-are creating a favorable policy environment for investment and innovation in this domain. With aging populations, rising urban morbidity, and the continuing threat of respiratory pandemics, the role of endotherapy in managing pulmonary health is set to grow substantially. Future devices are expected to become more affordable, personalized, and digitally connected, securing a long-term trajectory of growth for this high-impact medical segment.

SCOPE OF STUDY:

The report analyzes the Respiratory Endotherapy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Diagnostic Devices, Therapeutic Devices); Specialist (Hospitals Specialist, Diagnostic Centers Specialist, Ambulatory Surgery Centers Specialist); End-Use (Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use, Interventional Radiology End-Use, Venous End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Ambu
  • Armstrong Medical
  • Boston Scientific
  • CONMED Corporation
  • Cook Medical
  • Dragerwerk
  • Fisher & Paykel Healthcare
  • Flexicare Medical
  • Getinge
  • Halyard Health (Avanos Medical)
  • Hudson RCI
  • Intersurgical
  • Karl Storz
  • Laerdal Medical
  • Medtronic
  • Olympus
  • PENTAX Medical
  • Philips (Philips Respironics)
  • ResMed
  • Teleflex

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Respiratory Endotherapy Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Respiratory Diseases Propels Demand for Endotherapy Interventions
    • Aging Global Population Base Strengthens Business Case for Minimally Invasive Pulmonary Procedures
    • Increased Diagnosis Rates of COPD and Asthma Accelerate Device Utilization in Bronchoscopic Therapies
    • Advances in Flexible Endoscopic Technologies Expand Addressable Market for Precision Treatment
    • Surge in Demand for Non-Surgical Alternatives Spurs Adoption of Respiratory Endotherapy Devices
    • Integration of Imaging-Guided Navigation Systems Enhances Procedure Success and Market Uptake
    • Emergence of Endobronchial Valves and Coils Drives Innovation in Severe Emphysema Treatment
    • Growing Focus on Daycare and Outpatient Bronchoscopy Strengthens Demand for Disposable Instruments
    • Hospital Budget Constraints Propel Preference for Reusable and Sterilizable Device Configurations
    • Expanding Adoption in Lung Cancer Diagnosis and Palliative Care Broadens Use-Case Scenarios
    • Clinical Trials and Regulatory Approvals Accelerate Market Penetration of Novel Endotherapy Solutions
    • Public and Private Investment in Respiratory Research Fuels Device Development Pipelines
    • Increased Demand for Airway Stenting and Dilatation Enhances Market Versatility
    • High Burden of Smoking-Related Lung Damage Throws the Spotlight on Therapeutic Endoscopy
    • Integration with AI-Based Bronchoscopic Mapping Systems Drives Procedural Efficiency
    • Surge in ICU Admissions and Ventilation-Related Complications Boosts Procedural Frequency
    • Training and Simulation Tools Enhance Adoption Rates Among Pulmonologists and Interventionalists
    • Decentralization of Respiratory Care to Ambulatory Settings Expands Market Reach
    • Innovations in Biodegradable Implants Open New Frontiers in Chronic Disease Management
    • Rising Healthcare Spending in Emerging Markets Spurs Procurement of Advanced Endotherapy Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Respiratory Endotherapy Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Venous End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Peripheral Vascular Intervention End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Endovascular Interventions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cardiac End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Interventional Radiology End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Diagnostic Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • JAPAN
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • CHINA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: China 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • EUROPE
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • FRANCE
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: France 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • GERMANY
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • INDIA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: India 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • AFRICA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제